Cargando…

p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer

INTRODUCTION: Endocrine therapy is the most important treatment option for women with hormone receptor-positive breast cancer. The potential mechanisms for endocrine resistance involve estrogen receptor (ER)-coregulatory proteins and cross-talk between ER and other growth factor-signaling networks....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamashita, Hiroko, Toyama, Tatsuya, Nishio, Mariko, Ando, Yoshiaki, Hamaguchi, Maho, Zhang, Zhenhuan, Kobayashi, Shunzo, Fujii, Yoshitaka, Iwase, Hirotaka
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779473/ https://www.ncbi.nlm.nih.gov/pubmed/16869955 http://dx.doi.org/10.1186/bcr1536

Ejemplares similares

Phosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer
por: Yamashita, Hiroko, et al.
Publicado: (2005)

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer
por: Yamashita, Hiroko, et al.
Publicado: (2004)

Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients
por: Toyama, Tatsuya, et al.
Publicado: (2007)

Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast
por: Zhang, Zhenhuan, et al.
Publicado: (2003)

Reproductive history and breast cancer risk
por: Kobayashi, Shunzo, et al.
Publicado: (2012)

Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers
por: Toyama, Tatsuya, et al.
Publicado: (2008)

Estrogen Receptor, c‐erbB‐2 and nm23/NDP Kinase Expression in the Intraductal and Invasive Components of Human Breast Cancers
por: Kobayashi, Shunzo, et al.
Publicado: (1992)

Ratio of Expression of p16(INK4a) to p14(ARF) Correlates with the Progression of Non‐small Cell Lung Cancer
por: Moriyama, Satoru, et al.
Publicado: (2002)

Analysis of Oncogenes and Tumor Suppressor Genes in Human Breast Cancer
por: Yamashita, Hiroko, et al.
Publicado: (1993)

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
por: Okumura, Yasuhiro, et al.
Publicado: (2008)

Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer
por: Kai, Kazuharu, et al.
Publicado: (2008)

Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treatment in premenopausal patients with endocrine-responsive breast cancer: a randomized controlled trial
por: Ohashi, Yasuo, et al.
Publicado: (2017)

Production of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Breast Carcinomas
por: Iwata, Hiroji, et al.
Publicado: (1996)

Genetic and environmental factors and serum hormones, and risk of estrogen receptor-positive breast cancer in pre- and postmenopausal Japanese women
por: Guo, Jiazhi, et al.
Publicado: (2017)

A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer
por: Shiba, Eiichi, et al.
Publicado: (2015)

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer
por: Yamamoto, Yutaka, et al.
Publicado: (2013)

DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers
por: Iwase, H, et al.
Publicado: (1999)

Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer
por: Endo, Yumi, et al.
Publicado: (2014)

Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis
por: Iwahashi, Naoyuki, et al.
Publicado: (2022)

Particular gene upregulation and p53 heterogeneous expression in TP53-mutated maxillary carcinoma
por: Kudo, Itsuhiro, et al.
Publicado: (2017)

p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors
por: Yamamoto, Mitsugu, et al.
Publicado: (2014)

GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development
por: Kuwahara, Kazuhiko, et al.
Publicado: (2016)

Relationship Between Retinal Microcirculation and Renal Function in Patients with Diabetes and Chronic Kidney Disease by Laser Speckle Flowgraphy
por: Iwase, Takeshi, et al.
Publicado: (2023)

Nuclear Accumulation of p53 Protein Correlates with Mutations in the p53 Gene on Archival Paraffin‐embedded Tissues of Human Breast Cancer
por: Umekita, Yoshihisa, et al.
Publicado: (1994)

First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis
por: Shimoi, Tatsunori, et al.
Publicado: (2020)

A follow-up study of a randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-month depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer
por: Kurebayashi, Junichi, et al.
Publicado: (2021)

PTIP Associated protein 1, PA1, Is an Independent Prognostic Factor for Lymphnode Negative Breast Cancer
por: Takeshita, Takashi, et al.
Publicado: (2013)

(18)F-FDG PET/CT Imaging Post Heart Transplantation Depicts High Accumulation at Sites of Previous Ventricular Assist Device Insertion
por: Toyama, Yoshitaka, et al.
Publicado: (2023)

Relapsed multiple myeloma manifesting as extramedullary plasmacytoma of the breast: Imaging findings
por: Urano, Misugi, et al.
Publicado: (2019)

Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer
por: Horii, R, et al.
Publicado: (2007)

Improvement in medical students’ communication and interpersonal skills as evaluated by patient satisfaction questionnaire after curriculum reform
por: Oda, Yasutomo, et al.
Publicado: (2014)

The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
por: Omura, Go, et al.
Publicado: (2017)

Selective Estrogen Receptor Modulators Suppress Hif1α Protein Accumulation in Mouse Osteoclasts
por: Morita, Mayu, et al.
Publicado: (2016)

Changes in choriocapillaris and retinal morphology after laser photocoagulation by OCT angiography: A case report
por: Iwase, Takeshi, et al.
Publicado: (2018)

Myoepithelial Carcinoma of the Breast Treated with Surgery and Chemotherapy
por: Endo, Yumi, et al.
Publicado: (2013)

Collaborative care intervention for the perceived care needs of women with breast cancer undergoing adjuvant therapy after surgery: a feasibility study
por: Momino, Kanae, et al.
Publicado: (2017)

Indications for lateral lymph node dissection in patients with rectal neuroendocrine tumors: A case report and review of the literature
por: Fujii, Yoshiaki, et al.
Publicado: (2021)

p53 Accumulation in Colorectal Cancer with Hepatic Metastasis
por: Maruyama, Keiji, et al.
Publicado: (1996)

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
por: Daruwalla, Cyrus, et al.
Publicado: (2023)

TP53 alterations in relapsed childhood acute lymphoblastic leukemia
por: Yu, Chih‐Hsiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0t4bad754lg7lbq0svg7241u65